There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Invitae (NVTA – Research Report), HCA Healthcare (HCA – Research Report) and Atreca (BCEL – Research Report) with bullish sentiments. Invitae (NVTA) In a report issued on April 5, Puneet Souda from Leerink Partners maintained a Buy rating on Invitae. The company's shares closed last Wednesday at $7.66, close to its 52-week low of $6.06. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-invitae-nvta-hca-healthcare-hca?utm_source=advfn.com&utm_medium=referral
Invitae (NYSE:NVTA)
Historical Stock Chart
From Jul 2022 to Aug 2022 Click Here for more Invitae Charts.
Invitae (NYSE:NVTA)
Historical Stock Chart
From Aug 2021 to Aug 2022 Click Here for more Invitae Charts.